Stocks · News reference
Option Care Health, Pacira Biosciences and HealthStream show overbought RSI levels above 83, warning momentum-focused investors.
Reference Details
Poisar stores the source's headline, summary and market tags for reference. Reporting and full article text remain with the original publisher.
Keep reading
Freedom Capital Markets analyst Gene Mannheimer initiates coverage on HealthStream (NASDAQ:HSTM) with a Hold rating and announces Price Target of $36.
Filed: 2026-09-23 AccNo: 0001437749-26-031062 Size: 158 KB Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
- SEC Filing
Major M&A deals this week include Viatris buys Pacira BioSciences, TowneBank acquires blueharbor, Energy Transfer buys Vacquero Midstream.
UBS analyst A.J. Rice downgrades Option Care Health (NASDAQ:OPCH) from Buy to Neutral and lowers the price target from $39 to $32.05.
William Blair analyst Matt Larew downgrades Option Care Health (NASDAQ:OPCH) from Outperform to Market Perform.